Myricx Bio (private company)
See something wrong or missing? Let us know
Offices:London
Industry:Health servicesPharma
Business model:B2B
Myricx Bio, formerly Myricx Pharma, is a drug discovery company focused on developing small molecule inhibitors that selectively target the human N-myristoyltransferases (NMT) in cancer
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 120.02M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Myricx Bio
Name | Criteria | |
---|---|---|
![]() |
Ability Pharma
57%
|
|
![]() |
AbolerIS Pharma
57%
|
|
![]() |
Acesion Pharma
57%
|
|
![]() |
Beckley Psytech
57%
|
|
![]() |
Bigfinite
57%
|
|
![]() |
Forendo Pharma
57%
|
|
![]() |
NMD Pharma
57%
|
|
![]() |
Ona Therapeutics
57%
|
|
![]() |
Sanifit Therapeutics
57%
|
|
![]() |
Synapse Medicine
57%
|
|